Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib
BTK 抑制剂阿卡替尼治疗慢性淋巴细胞白血病 (CLL) 的靶标占据率的临床和生物学意义
期刊:Blood
影响因子:21
doi:10.1182/blood.2019003715
Clare Sun, Pia Nierman, Ellen K Kendall, Jean Cheung, Michael Gulrajani, Sarah E M Herman, Christopher Pleyer, Inhye E Ahn, Maryalice Stetler-Stevenson, Constance M Yuan, Irina Maric, Erika M Gaglione, Hailey M Harris, Stefania Pittaluga, Min Hui Wang, Priti Patel, Mohammed Z H Farooqui, Raquel Izum